Apparently conflicting results have been reported regarding the role of env glycoprotein glycans in human immunodeficiency virus type 1 (HIV-1) infectivity and cytopathogenicity. Whereas we have shown that enzymic removal of carbohydrates from mature envelope glycoproteins has only limited effect on the ability of HIV-1 to bind to CD4 and to infect target cells, sugar analogues that interfere with the glycosylation process of the nascent molecule markedly reduce virus infectivity. Here we have investigated the effect of a glucosidase inhibitor, 1-deoxynojirimycin (dNM), on the bioactivity and immunoreactivity of precursor gp160 produced by recombinant vaccinia virus-infected BHK-21 cells (rgp160). dNM (4 mm) did not affect the amount of rgp160 recovered nor its secretion from the cells. As described by other authors the effect of dNM was incomplete, resulting in the production of rgp160, the glycosylation of which was heterogeneous with respect to apparent Mr distribution and to sensitivity to endoglycosidase H and endoglycosidase F, all the species being susceptible to N-glycanase. A major reduction of the binding to CD4+ cells was noted with rgp160 produced by dNM-treated cells using a quantitative indirect immunofluorescence assay and labelling with polyclonal human anti-HIV IgG. Similarly, dNM treatment altered the accessibility to murine monoclonal antibody 110-4 of the exposed V3 loop of HIV-1 gp120 by at least 10-fold, as determined by either ELISA capture assay or immunoaffinity purification. Such bioactivity and conformation modifications, which result from the abnormal folding of the nascent glycoprotein due to aberrant glycosylation, may account for the impaired HIV-1 infectivity elicited by dNM.
AlizonM.,
Wain-HobsonS.,
MontagnierL.,
SonigoP.1986; Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell 46:63–74
AndersonO.,
SorensenA. M.,
SvehagS.,
FenouilletE.1991; Conglutinin binds the HIV-1 envelope glycoprotein gp160 and inhibits its interaction with cell membrane CD4. Scandinavian Journal of Immunology 33:81–88
ChakrabartiL.,
GuyaderM.,
AlizonM.,
DanielM. D.,
DesrosiersR. C.,
TiollaisP.,
SonigoP.1987; Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature, London 328:543–547
DavisD.,
StephensD. M.,
WillersC.,
LachmannP. J.1990; Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1. Journal of General Virology 71:2889–2898
FenouilletE.,
FayetG.,
HovsepianS.,
BahraouiE.,
RoninC.1986; Immunochemical evidence for a role of complex carbohydrate chains in thyroglobulin antigenicity. Journal of Biological Chemistry 261:15153–15158
FenouilletE.,
Clerget-RaslainB.,
GluckmanJ. C.,
GuetardD.,
MontagnierL.,
BahraouiE.1989; Role of JV-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Journal of Experimental Medicine 169:807–822
FenouilletE.,
GluckmanJ. C.,
BahraouiE.1990; Role of JV-linked glycans of envelope glycoproteins in infectivity of HIV-1. Journal of Virology 64:2841–2848
FreedE. O.,
MyersD. J.,
RisserR.1990; Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proceedings of the National Academy of Sciences, U.S.A 87:4650–4654
GibsonR.,
KornfeldS.,
SchlesingerS.1981; The effect of oligosaccharide chains of different sizes on the maturation and physical properties of the G protein of vesicular stomatitis virus. Journal of Biological Chemistry 256:456–462
GrutersR. A.,
NeefjesJ. J.,
TersmetteM.,
De GoedeR. E. V.,
HuismanG.,
MiedemaF.,
PloeghH. L.1987; Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature, London 330:74–77
HansenJ. E. S.,
NielsenC. M.,
NielsenC.,
HeegaardP.,
MathiesenL. R.,
NielsenJ. O.1989; Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins. AIDS 3:635–641
JarvisD. L.,
SummersM. D.1989; Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Molecular and Cellular Biology 9:214–223
KarpasA.,
FleetG. W. J.,
DwekR. A.,
PeturssonS.,
NamgoongS. K.,
RamsdenN. G.,
JacobG. S.,
RademacherT. W.1988; Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proceedings of the National Academy of Sciences, U.S.A 85:9229–9233
KienyM. P.,
LatheR.,
RiviereY.,
DoitK.,
SchmittD.,
GirardM.,
MontagnierL.,
LecocqJ. P.1988; Improved antigenicity of the HIV env protein by cleavage site removal. Protein Engineering 2:219–225
KozarskyK.,
PenmanM.,
BasiripourL.,
HaseltineW.,
SodroskiJ.,
KriegerM.1989; Glycosylation and processing of the human immunodeficiency virus envelope protein. Journal of Acquired Immune Deficiency Syndromes 2:163–169
LifsonJ.,
CoutreS.,
HuangE.,
EnglemanE.1986; Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. Journal of Experimental Medicine 64:2101–2120
McCuneJ.,
RabinL. B.,
FeinbergM. B.,
LiebermanM.,
KosekJ. C.,
ReyesG. R.,
WeissmanI. L.1989; Endoproteolytic cleavage of gpl60 is required for the activation of human immunodeficiency virus. Cell 53:55–67
MatthewsT. J.,
WeinholdK. J.,
LyerlyH. K.,
LangloisA. J.,
WigzelH.,
BolognesiD.1987; Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gpl20 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proceedings of the National Academy of Sciences, U.S.A. 84:5424–5428
MizuochiT.,
SpellmanM. W.,
LarkinM.,
SolomonJ.,
BasalL. J.,
FeiziT.1988; Carbohydrate structures of the human immunodeficiency virus (HIV) recombinant envelope glycoprotein E. Fenouillet and J.-C. Gluckman gp120 produced in Chinese hamster ovary cells. Biochemical Journal 254:599–603
MeloenR. H.,
LiskampR. M.,
GoudsmitJ.1989; Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity. Journal of General Virology 70:1505–1512
MontefioriD. C.,
RobinsonW. E.,
MitchellW. M.1988; Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, U.S.A. 85:9248–9252
MorikawaY.,
MooreJ. P.,
JonesI. M.1990a; HIV-1 envelope protein gpl20 expression by secretion in E. coli: assessment of CD4 binding and use in epitope mapping. Journal of Virological Methods 29:105–114
MorikawaY.,
OvertonH. A.,
MooreJ. P.,
WilkinsonA. J.,
BradyR. L.,
LewisS.,
JonesI. M.1990b; Expression of HIV-1 gp120 and human soluble CD4 by recombinant baculoviruses and their interaction in vitro
. AIDS Research and Human Retroviruses 6:765–773.
OldenK.,
BernardB. A.,
HumphriesM. J.,
YeoT. K.,
WhiteS. L.,
NewtonS. A.,
BadeH. C.,
ParentJ. B.1985; Function of glycoprotein glycans. Trends in Biochemical Sciences February 78–81
PalR.,
HokeG. M.,
SarngadharanM. G.1989a; Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, U.S.A 86:3384–3388
PalR.,
KalyanaramanV. S.,
HokeG. M.,
SarngadharanM. G.1989a; Processing and secretion of envelope glycoproteins of HIV-1 in the presence of trimming glucosidase inhibitor deoxynojirimycin. Intervirology 30:27–35
ParryN.,
FoxG.,
RowlandsD.,
BrownF.,
FryE.,
AcharyaR.,
LoganD.,
StuartD.1990; Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature, London 347:569–572
RobinsonE. R.,
MontefioriD. C.,
MitchellW. M.1987; Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 pathogenesis. AIDS Research and Human Retroviruses 3:265–281
TarentinoA. L.,
TrimbleR. B.,
PlummerT. H.1989; Enzymatic approaches for studying the structure, synthesis, and processing of glycoproteins. Methods in Cell Biology 32:111–139
TilleyS.,
HonnenW.,
RachoM.,
HilgartnerM.,
PinterA.1991; Human monoclonal antibodies against the putative CD4 binding site and the V3 loop of HIV gp 120 act in concert to neutralize virus. Abstract MA 70. VII International Conference on AIDS. Florence June 16–21